Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Claris Biotherapeutics, Inc. See All Filings	D	2025-09-22 10:20:23 UTC
Amount To Be Raised $2,300,000 Associated Brokers / Dealers N/A CIK Number 0001809726 Filed Document 0001809726-25-000004 Exclusions or Exemptions 506b Accepted Date 2025-09-22 10:20:23 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Debt
Claris Biotherapeutics, Inc. See All Filings	D	2025-03-07 15:35:01 UTC
Amount To Be Raised $3,300,000 Associated Brokers / Dealers N/A CIK Number 0001809726 Filed Document 0001809726-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-03-07 15:35:01 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Debt
Claris Biotherapeutics, Inc. See All Filings	D	2024-01-08 16:31:15 UTC
Amount To Be Raised $9,999,998 Associated Brokers / Dealers N/A CIK Number 0001809726 Filed Document 0001809726-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-01-08 16:31:15 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Claris Biotherapeutics, Inc. See All Filings	D/A	2023-10-24 14:57:50 UTC
Amount To Be Raised $44,499,994 Associated Brokers / Dealers N/A CIK Number 0001809726 Filed Document 0001809726-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-10-24 14:57:50 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Claris Biotherapeutics, Inc. See All Filings	D	2020-04-27 10:36:04 UTC
Amount To Be Raised $25,999,999 Associated Brokers / Dealers N/A CIK Number 0001809726 Filed Document 0001809726-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-04-27 10:36:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity